January 13, 2018 – By Louis Casey

Among 52 analysts covering Apple Inc. (NASDAQ:AAPL), 40 have Buy rating, 1 Sell and 11 Hold. Therefore 77% are positive. Apple Inc. had 344 analyst reports since July 21, 2015 according to SRatingsIntel. Goldman Sachs maintained the shares of AAPL in report on Thursday, July 13 with “Buy” rating. On Friday, December 1 the stock rating was downgraded by Gabelli to “Hold”. As per Thursday, January 19, the company rating was downgraded by OTR Global. The firm has “Buy” rating by Oppenheimer given on Friday, September 4. The stock of Apple Inc. (NASDAQ:AAPL) earned “Market Perform” rating by Cowen & Co on Tuesday, August 25. Canaccord Genuity maintained the stock with “Buy” rating in Monday, November 20 report. The rating was maintained by Piper Jaffray on Friday, August 14 with “Overweight”. The rating was maintained by Goldman Sachs with “Buy” on Monday, February 13. Drexel Hamilton maintained Apple Inc. (NASDAQ:AAPL) on Friday, June 2 with “Buy” rating. The stock of Apple Inc. (NASDAQ:AAPL) has “Buy” rating given on Monday, June 12 by Citigroup. See Apple Inc. (NASDAQ:AAPL) latest ratings:

05/01/2018 Broker: UBS Rating: Buy New Target: $190.0 Maintain
02/01/2018 Broker: Piper Jaffray Rating: Buy New Target: $200.0 Maintain
18/12/2017 Broker: BMO Capital Markets Rating: Buy New Target: $199.0 Maintain
19/12/2017 Broker: Nomura Rating: Hold New Target: $175.0 Downgrade
19/12/2017 Broker: Instinet Old Rating: Buy New Rating: Neutral Downgrade
13/12/2017 Broker: Citigroup Rating: Buy New Target: $200.0 Maintain
07/12/2017 Broker: KeyBanc Capital Markets Rating: Buy New Target: $192.0 Maintain
04/12/2017 Broker: Tigress Financial Rating: Buy Maintain
01/12/2017 Broker: Gabelli Rating: Hold Downgrade
01/12/2017 Broker: Guggenheim Rating: Buy New Target: $215.0 Maintain

Analysts expect Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) to report $-0.36 EPS on February, 8.After having $-0.38 EPS previously, Dova Pharmaceuticals, Inc.’s analysts see -5.26% EPS growth. The stock increased 0.68% or $0.2 during the last trading session, reaching $29.72. About 25,223 shares traded. Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) has 0.00% since January 13, 2017 and is . It has underperformed by 16.70% the S&P500.

Since August 7, 2017, it had 0 buys, and 12 insider sales for $93.68 million activity. The insider Riccio Daniel J. sold $2.73 million. Shares for $1.70M were sold by Srouji Johny. COOK TIMOTHY D had sold 268,623 shares worth $43.15 million. 35,000 shares were sold by LEVINSON ARTHUR D, worth $5.52M. On Tuesday, October 3 the insider AHRENDTS ANGELA J sold $9.78 million. FEDERIGHI CRAIG had sold 63,163 shares worth $9.98 million. $8.79 million worth of stock was sold by SCHILLER PHILIP W on Tuesday, October 3.

Investors sentiment increased to 0.7 in Q3 2017. Its up 0.02, from 0.68 in 2017Q2. It increased, as 52 investors sold Apple Inc. shares while 1034 reduced holdings. 116 funds opened positions while 640 raised stakes. 2.97 billion shares or 2.78% less from 3.06 billion shares in 2017Q2 were reported. Manchester Mgmt Llc accumulated 1.29% or 54,219 shares. Pennsylvania-based Argyle Capital Mgmt Incorporated has invested 0.09% in Apple Inc. (NASDAQ:AAPL). 1832 Asset Management L P holds 1.71M shares. 1.14M are owned by South Dakota Inv Council. Forbes J M And Com Llp holds 2.97% or 77,197 shares in its portfolio. Moreover, Gilder Gagnon Howe And Ltd has 0.06% invested in Apple Inc. (NASDAQ:AAPL) for 26,634 shares. Pacad Inv Limited invested in 0.51% or 15,068 shares. Pinebridge Invs Limited Partnership holds 424,813 shares or 1.57% of its portfolio. Asset Management Incorporated holds 0.95% of its portfolio in Apple Inc. (NASDAQ:AAPL) for 366,298 shares. Fincl Mgmt Professionals has invested 0.19% in Apple Inc. (NASDAQ:AAPL). Benin Management Corporation accumulated 28,344 shares. 29.68 million were reported by Tiaa Cref Investment Limited Liability. 2,541 are owned by Clearbridge Ltd Liability. 44,398 are owned by Miracle Mile Advsrs Lc. 27,222 are held by Citizens Northern.

The stock increased 1.03% or $1.81 during the last trading session, reaching $177.09. About 25.42 million shares traded. Apple Inc. (NASDAQ:AAPL) has risen 62.48% since January 13, 2017 and is uptrending. It has outperformed by 45.78% the S&P500.

Apple Inc. designs, manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players to consumers, small and mid-sized businesses, and education, enterprise, and government clients worldwide. The company has market cap of $900.87 billion. The firm also sells related software, services, accessories, networking solutions, and third-party digital content and applications. It has a 19.23 P/E ratio. It offers iPhone, a line of smartphones; iPad, a line of multi-purpose tablets; and Mac, a line of desktop and portable personal computers.

Dova Pharmaceuticals, Inc., a pharmaceutical company, focuses on acquiring, developing, and commercializing drug candidates for thrombocytopenia diseases. The company has market cap of $762.39 million. The Company’s drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist that has completed Phase III clinical trials for the treatment of thrombocytopenia in patients with chronic liver diseases. It currently has negative earnings.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our daily email newsletter.




Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here